Michael Petusky

Stock Analyst at Barrington Research

(0)
# 4446
Out of 5,333 analysts
196
Total ratings
31.10%
Success rate
-14.03%
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
HSIC Henry Schein
Maintains: Outperform
90 86
68.67 25.24% 14 May 6, 2025
OPK OPKO Health
Maintains: Outperform
3 3
1.25 80% 12 May 1, 2025
OPCH Option Care Health
Maintains: Outperform
38 38
31.91 19.08% 15 Apr 30, 2025
MMSI Merit Medical Systems
Maintains: Outperform
111 103
95.83 7.48% 20 Apr 25, 2025
ANIK Anika Therapeutics
Maintains: Outperform
25 20
11.65 71.67% 16 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
2 2
0.77 62.34% 9 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 6
1.18 408.47% 14 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 20
15.82 26.42% 18 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
108 98
74.13 32.2% 22 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 9 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
108 95
68.33 39.03% 23 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 12
n/a n/a 6 Oct 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jul 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
n/a n/a 1 Jun 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 18, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 1 Aug 11, 2016